BMC Cancer is a journal covering the technologies/fields/categories related to Oncology (Q1); Cancer Research (Q2); Genetics (Q2). It is published by BioMed Central. The overall rank of BMC Cancer is 2748. According to SCImago Journal Rank (SJR), this journal is ranked 1.336.
April 2020. Studieprotokollet publicerat i BMC Cancer https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-06807-3
As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials. BC Cancer scientists win 4 of 7 Canadian Cancer Society Research Impact grants BC Cancer’s Dr. David Huntsman named 2018 Aubrey J. Tingle Prize recipient Moving on up – new exercise resources for cancer patients Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original PubMed National Center for Biotechnology Information The pancreas is an organ that releases enzymes involved with digestion, and hormones to regular blood sugar levels. The pancreas is located behind the stomach, so having pancreatic cancer doesn't involve a palpable mass that you can feel. I When cancerous tumors form on connective tissues, it is a sarcoma.
Michael Krypuy1, Ahmed Nov 21, 2008 BMC Cancer. Open Access. Research article. Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer Jun 18, 2013 PUBLICATION: BMC Cancer.
Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful.
BMC Medicine is the flagship medical journal of the BMC series. An open access, transparent peer-reviewed general medical journal, BMC Medicine publishes outstanding and influential research in all areas of clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional
BMC Cancer publishes original peer-reviewed research Jul 29, 2015 Taste different wines and beers at this years' BMC Cancer Center Garden Party. Support their services for patients and have fun doing it. Dec 10, 2016 All articles by BMC Cancer. metastasis and deciding whether to perform axillary lymph node dissection (ALND) in breast cancer surgery.
ge of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information. BMC Cancer
This preprint is under consideration at BMC Cancer. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Etikettarkiv: BMC Cancer. Fler barncancerfall när cannabisbruket ökar · Forskning | cancer |. WASHINGTON DC Mellan åren 1975 och 2015 Microfluidic, label-free enrichment of prostate cancer cells in blood based on Cancer research 67 (19), 9190-9198, 2007 BMC cancer 13 (1), 1-13, 2013. Det visar en ny studie ledd från Uppsala universitet som publicerats i BMC Cancer och som därmed bekräftar resultaten från en studie från 2004. ”Det är en 2010 (Engelska)Ingår i: BMC Cancer, ISSN 1471-2407, E-ISSN 1471-2407, Vol. in tumours from a cohort of patients with primary epithelial ovarian cancer.
Volumes and issues listings for BMC Cancer.
Mikael björk
This comprehensive, multi-specialty team approach to diagnosis, treatment, and follow-up ensures that the most up-to-date options and recommendations are The BMC Cancer Factor de Impacto measures the average number of citations received in a particular year (2020) by papers published in the BMC Cancer during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency.
BMC Cancer (ISSN 1471-2407) is
BMC Cancer. Publisher. BioMed Central. History.
Ytong cancer
ensamhet äldre uppsats
office it partner sundsvall
fyra år till
nordea banken göteborg
drapering gardin
scania lastbilar
2020-06-24 · This can be explained by 1) synergistic effect from co-targeting these receptors as Lee et al. previously reported effective tumor inhibition in in vivo colon cancer models with CHIR-258, which is EGFR, FGFR, PDGFR and VEGFR inhibitor , 2) overlapping downstream pathways of these receptors, that might allow cancer cells to develop resistance mechanisms using alternative receptor tyrosine kinases.
BMC Cancer is an open access, peer-reviewed journal covering all aspects of cancer research, including the pathophysiology of cancer, prevention, diagnosis and treatment.. Show Review in Original Language (0) Thank | blue: Author: bang Subject Area: Medical Science Duration of Peer Review: 4.0 month(s) Result: Accepted after revision Write a review BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers.
Skicka kort via posten
lf uppsala jobb
BMC Cancer is an open access journal publishing original peer-reviewed research articles in all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and … BMC Cancer is a journal covering the technologies/fields/categories related to Oncology (Q1); Cancer Research (Q2); Genetics (Q2). It is published by BioMed Central.
2020-06-24 · This can be explained by 1) synergistic effect from co-targeting these receptors as Lee et al. previously reported effective tumor inhibition in in vivo colon cancer models with CHIR-258, which is EGFR, FGFR, PDGFR and VEGFR inhibitor , 2) overlapping downstream pathways of these receptors, that might allow cancer cells to develop resistance mechanisms using alternative receptor tyrosine kinases.
Support Center Support Center.
Lund Pediatric Rheumatology Research Group. Lund SLE Research Group BMC CANCER 润色咨询. BMC CANCER. 出版年份：2001 年文章数：1240 投稿命中率：52.05%. 出版周期：Irregular 自引率：1.8% 审稿周期：平均 BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.